Literature DB >> 6733885

Hydrogen peroxide contrast echocardiography: quantification in vivo of myocardial risk area during coronary occlusion and of the necrotic area remaining after myocardial reperfusion.

A J Kemper, J E O'Boyle, C A Cohen, A Taylor, A F Parisi.   

Abstract

During sustained coronary occlusion in canine preparations, the extent of regions that fail to show contrast enhancement when imaged by supra-aortic hydrogen peroxide contrast echocardiography (SHPCE) has been shown to correlate well for single cross sections with the extent of malperfused myocardium "at risk" of infarction. In the present study, SHPCE was investigated as a means of determining the fraction of total left ventricular mass at risk during occlusion. Since necrotic tissue has low blood flow even when reperfused, we also investigated the potential of quantitating the extent of infarcted myocardium by measuring the extent of contrast defects seen with SHPCE performed during reperfusion. In 20 dogs the fraction of the left ventricle showing a contrast defect during coronary occlusion correlated well with the fraction of the left ventricular mass "at risk" by an autoradiographic technique (autoradiography = 0.83 echocardiography + 8.6%; r = .89, SEE = 4.5%). SHPCE was also performed after 3 hr of reperfusion following occlusions varying in duration from 60 to 150 min. The fraction of the ventricle showing a contrast defect during reperfusion predicted the infarcted portion of the left ventricle as shown by triphenyl tetrazolium chloride staining (% left ventricle infarcted = 0.81 echocardiography + 3.3%; r = .84, SEE = 5.3%). Observer variability for the fraction of the ventricle showing a contrast defect was excellent during both occlusion and reperfusion. The ratio of the left ventricular extent of contrast-negative regions during reperfusion and occlusion was used to calculate a necrosis-to-risk index in vivo that correlated relatively well with the myocardial necrosis-to-risk ratio determined morphologically (r = .77, SEE = 16%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733885     DOI: 10.1161/01.cir.70.2.309

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

Review 1.  Imaging techniques for coronary artery disease: current status and future directions.

Authors:  C N Merz; D S Berman
Journal:  Clin Cardiol       Date:  1997-06       Impact factor: 2.882

Review 2.  The need for imaging in acute myocardial infarction.

Authors:  A F Parisi
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

3.  Evaluation of collateral blood flow by myocardial contrast enhanced echocardiography.

Authors:  P Widimsky; J H Cornel; F J ten Cate
Journal:  Br Heart J       Date:  1988-01

Review 4.  Echocardiography and coronary artery disease: current and future applications.

Authors:  W F Armstrong
Journal:  Int J Card Imaging       Date:  1987

5.  Enhanced methods for visualizing myocardial perfusion with peripheral venous injection of levovist: application of triggered harmonic imaging and triggered harmonic power Doppler imaging techniques.

Authors:  K Hirooka; K Miyatake; A Hanatani; K Komamura; S Nakatani; Y Yasumura; M Yamagishi
Journal:  Int J Card Imaging       Date:  2000-08

Review 6.  Imaging microvascular obstruction and its clinical significance following acute myocardial infarction.

Authors:  Albert K Luo; Katherine C Wu
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

7.  Air-filled proteinaceous microbubbles: synthesis of an echo-contrast agent.

Authors:  M W Grinstaff; K S Suslick
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

Review 8.  Myocardial Contrast Echocardiography in the Evaluation of Hypertensive Heart Disease.

Authors:  Ernest C Madu; Chiranjivi Potu; Dainia Baugh; Edwin Tulloch-Reid
Journal:  Cardiol Res       Date:  2011-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.